Literature DB >> 14747542

Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the respiratory syncytial virus G protein.

L de Waal1, S Yüksel, A H Brandenburg, J P M Langedijk, K Sintnicolaas, G M G M Verjans, A D M E Osterhaus, R L de Swart.   

Abstract

The cellular immune response to respiratory syncytial virus (RSV) is important in both protection and immunopathogenesis. In contrast to HLA class I, HLA class II-restricted RSV-specific T-cell epitopes have not been identified. Here, we describe the generation and characterization of two human RSV-specific CD4(+)-T-cell clones (TCCs) associated with type 0-like cytokine profiles. TCC 1 was specific for the matrix protein and restricted over HLA-DPB1*1601, while TCC 2 was specific for the attachment protein G and restricted over either HLA-DPB1*0401 or -0402. Interestingly, the latter epitope is conserved in both RSV type A and B viruses. Given the high allele frequencies of HLA-DPB1*0401 and -0402 worldwide, this epitope could be widely recognized and boosted by recurrent RSV infections. Indeed, peptide stimulation of peripheral blood mononuclear cells from healthy adults resulted in the detection of specific responses in 8 of 13 donors. Additional G-specific TCCs were generated from three of these cultures, which recognized the identical (n = 2) or almost identical (n = 1) HLA-DP4-restricted epitope as TCC 2. No significant differences were found between the capacities of cell lines obtained from infants with severe (n = 41) or mild (n = 46) RSV lower respiratory tract infections to function as antigen-presenting cells to the G-specific TCCs, suggesting that the severity of RSV disease is not linked to the allelic frequency of HLA-DP4. In conclusion, we have identified an RSV G-specific human T helper cell epitope restricted by the widely expressed HLA class II alleles DPB1*0401 and -0402. Its putative role in protection and/or immunopathogenesis remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747542      PMCID: PMC369497          DOI: 10.1128/jvi.78.4.1775-1781.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

Review 1.  Respiratory syncytial virus immunobiology and pathogenesis.

Authors:  Barney S Graham; John A Rutigliano; Teresa R Johnson
Journal:  Virology       Date:  2002-05-25       Impact factor: 3.616

2.  Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus.

Authors:  Shisong Jiang; Nicola J Borthwick; Paul Morrison; George F Gao; Michael W Steward
Journal:  J Gen Virol       Date:  2002-02       Impact factor: 3.891

3.  Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine.

Authors:  Gregory A Prince; Spencer J Curtis; Kevin C Yim; David D Porter
Journal:  J Gen Virol       Date:  2001-12       Impact factor: 3.891

4.  Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection.

Authors:  J Chang; A Srikiatkhachorn; T J Braciale
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

5.  Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons.

Authors:  X Carbonell-Estrany; J Quero
Journal:  Pediatr Infect Dis J       Date:  2001-09       Impact factor: 2.129

6.  Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans.

Authors:  D M Koelle; S N Reymond; H Chen; W W Kwok; C McClurkan; T Gyaltsong; E W Petersdorf; W Rotkis; A R Talley; D A Harrison
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 7.  Respiratory syncytial virus infection.

Authors:  E A Simoes
Journal:  Lancet       Date:  1999-09-04       Impact factor: 79.321

8.  Immunopathogenesis of vaccine-enhanced RSV disease.

Authors:  P J Openshaw; F J Culley; W Olszewska
Journal:  Vaccine       Date:  2001-10-15       Impact factor: 3.641

9.  Increased replication of respiratory syncytial virus (RSV) in pulmonary infiltrates is associated with enhanced histopathological disease in bonnet monkeys (Macaca radiata) pre-immunized with a formalin-inactivated RSV vaccine.

Authors:  Esther M Ponnuraj; Anthony R Hayward; Anthony Raj; Harry Wilson; Eric A F Simoes
Journal:  J Gen Virol       Date:  2001-11       Impact factor: 3.891

10.  Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy.

Authors:  P Pala; R Bjarnason; F Sigurbergsson; C Metcalfe; N Sigurs; P J M Openshaw
Journal:  Eur Respir J       Date:  2002-08       Impact factor: 16.671

View more
  15 in total

1.  Expression of HLA-DP0401 molecules for identification of DP0401 restricted antigen specific T cells.

Authors:  Junbao Yang; Laurel Huston; Deanna Berger; Nancy A Danke; Andrew W Liu; Mary L Disis; William W Kwok
Journal:  J Clin Immunol       Date:  2005-09       Impact factor: 8.317

2.  HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Robert A Vierkant; V Shane Pankratz; Steven J Jacobsen; Gregory A Poland
Journal:  Immunogenetics       Date:  2005-01-27       Impact factor: 2.846

3.  Modulation of protective immunity, eosinophilia, and cytokine responses by selective mutagenesis of a recombinant G protein vaccine against respiratory syncytial virus.

Authors:  Yan Huang; Robert Anderson
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein.

Authors:  Yoshihiko Murata; Paula M Lightfoote; Jamie N Biear; Ann R Falsey; Edward E Walsh
Journal:  Vaccine       Date:  2010-07-23       Impact factor: 3.641

5.  Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.

Authors:  John Sidney; Amiyah Steen; Carrie Moore; Sandy Ngo; Jolan Chung; Bjoern Peters; Alessandro Sette
Journal:  J Immunol       Date:  2010-02-05       Impact factor: 5.422

6.  Structural and Nonstructural Viral Proteins Are Targets of T-Helper Immune Response against Human Respiratory Syncytial Virus.

Authors:  Elena Lorente; Alejandro Barriga; Eilon Barnea; Carmen Mir; John A Gebe; Arie Admon; Daniel López
Journal:  Mol Cell Proteomics       Date:  2016-04-18       Impact factor: 5.911

Review 7.  The host response and molecular pathogenesis associated with respiratory syncytial virus infection.

Authors:  Christine M Oshansky; Wenliang Zhang; Elizabeth Moore; Ralph A Tripp
Journal:  Future Microbiol       Date:  2009-04       Impact factor: 3.165

8.  Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia.

Authors:  Georges M G M Verjans; Rogier Q Hintzen; Jessica M van Dun; Angelique Poot; Johannes C Milikan; Jon D Laman; Anton W Langerak; Paul R Kinchington; Albert D M E Osterhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

9.  Development of a humanized HLA-A2.1/DP4 transgenic mouse model and the use of this model to map HLA-DP4-restricted epitopes of HBV envelope protein.

Authors:  Zhitao Ru; Wenjun Xiao; Anthony Pajot; Zhihua Kou; Shihui Sun; Bernard Maillere; Guangyu Zhao; David M Ojcius; Yu-Chun Lone; Yusen Zhou
Journal:  PLoS One       Date:  2012-03-05       Impact factor: 3.240

10.  Generation and expression analysis of BAC humanized mice carrying HLA-DP401 haplotype.

Authors:  Feng Li; Meng-Min Zhu; Bo-Wen Niu; Ling-Ling Liu; Xiu-Hua Peng; Hua Yang; Bo-Yin Qin; Meixiang Wang; Xiaonan Ren; Xiaohui Zhou
Journal:  Animal Model Exp Med       Date:  2021-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.